Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
M6620 First in Human Study
- Status
- COMPLETED
- Phase
- PHASE1
BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
- Status
- COMPLETED
- Phase
- PHASE3
Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE)
- Status
- TERMINATED
- Phase
- PHASE2
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies
- Status
- TERMINATED
- Phase
- PHASE2
Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE3
A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2